A drug that outperforms placebo in helping people to lose weight is one of a growing number of next-generation obesity drugs being produced in ... the drug lost up to 13.8 kilograms over 48 weeks of ...

Obesity remains one of the greatest health challenges worldwide, leading to diabetes, heart disease, and increased healthcare ...

Policymakers must prioritize access to innovative obesity care in tackling the obesity epidemic across the United States.

The increasing prevalence of overweight and obesity in China poses an urgent public health challenge requiring immediate ...

Ihuoma Eneli, MD, MS, discusses early intervention in childhood obesity to reduce long‑term risk and supporting families with ...

A separate Prime analysis, however, of year-over-year claims data for Wegovy and Zepbound only found an improvement in ...

Conversations between the patient and provider should focus on the stakes of antiobesity treatment and continuation, says ...

W. Timothy Garvey, M.D., served as lead author in the clinical trial. A new combination drug therapy is showing extraordinary ...

A clinical guidance from the American College of Cardiology Solution Set Oversight Committee states that pharmacotherapy may ...

The Ministry of Health and Prevention (MoHAP) has launched the National Clinical Guideline for Weight Management and ...

Doctors should provide high quality, evidence based care reflecting individual preferences and needs, regardless of weight, argue Juan Franco and colleagues Doctors have traditionally recommended ...

Researchers found that once-monthly maridebart cafraglutide led to substantial weight loss and improved glycemic control in ...